AUA Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AUA Capital Management's BMY Position: Q1 2024 in Review
AUA Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 3,937 shares — an estimated $202K sold.
AUA Capital Management first reported a position in BMY in Q4 2016 and held it in 29 quarters. The position peaked at $303K in Q2 2022. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- AUA Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- AUA Capital Management sold 3,937 Bristol-Myers Squibb shares in Q1 2024, an estimated $202K.
- AUA Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 29 quarters.
- AUA Capital Management's Bristol-Myers Squibb position peaked at $303K in Q2 2022.
- 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on AUA Capital Management's 13F filing for Q1 2024, filed 11 Apr 2024.